We are live on ! Find out more
CERO

CERo Therapeutics
CERO

Delisted

CERO was delisted on the 30th of October, 2025.

Back to rankings

36 hedge funds and large institutions have $104M invested in CERo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 0% → 0.03% (+0.03%)

Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Beryl Capital Management
California
+$12.2M
2
HCM
Highbridge Capital Management
New York
+$10.3M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.44M
4
SCM
Saba Capital Management
New York
+$6.35M
5
Marshall Wace
Marshall Wace
United Kingdom
+$6.23M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
Beryl Capital Management
California
$12.2M +$12.2M +615 New
HCM
2
Highbridge Capital Management
New York
$10.3M +$10.3M +519 New
CF
3
Cantor Fitzgerald
New York
$7.43M +$7.44M +375 New
Citadel Advisors
4
Citadel Advisors
Florida
$7.43M +$7.44M +375 New
SCM
5
Saba Capital Management
New York
$6.34M +$6.35M +320 New
Marshall Wace
6
Marshall Wace
United Kingdom
$6.21M +$6.23M +314 New
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$5.95M +$5.96M +300 New
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$4.72M +$4.72M +238 New
WAM
9
Weiss Asset Management
Massachusetts
$4.63M +$4.63M +233 New
ACM
10
Atalaya Capital Management
New York
$4.46M +$4.47M +225 New
AA
11
AQR Arbitrage
Connecticut
$3.29M +$3.3M +166 New
CL
12
CSS LLC
Illinois
$3.15M +$3.16M +159 New
RCM
13
Radcliffe Capital Management
Pennsylvania
$2.97M +$2.98M +150 New
WRBC
14
W.R. Berkley Corp
Connecticut
$2.94M +$2.94M +148 New
FTCM
15
Fir Tree Capital Management
New York
$2.48M +$2.48M +125 New
MI
16
MMCAP International
Cayman Islands
$2.48M +$2.48M +125 New
NAM
17
Nexpoint Asset Management
Texas
$2.15M +$2.16M +109 New
UOC
18
UBS O'Connor
Illinois
$2.04M +$2.04M +103 New
Hudson Bay Capital Management
19
Hudson Bay Capital Management
Connecticut
$1.98M +$1.99M +100 New
OCM
20
Oaktree Capital Management
California
$1.98M +$1.99M +100 New
CH
21
CVI Holdings
Delaware
$1.94M +$1.95M +98 New
WAM
22
Wolverine Asset Management
Illinois
$1.59M +$1.59M +80 New
SCC
23
Spring Creek Capital
Kansas
$991K +$993K +50 New
TCM
24
Tenor Capital Management
New York
$991K +$993K +50 New
SSA
25
Schonfeld Strategic Advisors
New York
$892K +$893K +45 New
1
2

CERO Hedge Fund Activity: Q4 2021 in Review

36 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q4 2021, worth a combined $104M.

Buyers outnumbered sellers: 36 funds opened new CERO positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $12.2M.

  • 36 institutional investors held CERo Therapeutics (CERO) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $104M of CERo Therapeutics stock for Q4 2021.
  • 36 funds opened new CERo Therapeutics positions in Q4 2021 and 0 closed out, a net change of +36 holders.
  • The largest CERo Therapeutics buyer in Q4 2021 was Beryl Capital Management, an estimated $12.2M added.

Based on aggregated 13F filings for Q4 2021.